Thomas Perlmann
InvestorAdvisor; Professor at Karolinska Institute and Secretary General of the Nobel Committee at EIR Ventures
Stockholm
About
PhD, professor of cell and molecular biology at the Karolinska Institute and Secretary General of the Nobel Committee. His research focuses on the development of the central nervous system and regenerative medicine, notably dopamine neurons relevant to Parkinson's disease.
Colleagues at EIR Ventures
Amanda Hayward
Founding Partner at EIR Ventures
Carani Sanjeevi
Advisor at EIR Ventures
Gökçe Günaydin
Principal at EIR Ventures
Harald Ekman
Co-founder and CFO at EIR Ventures
Lovisa Backemar
Partner at EIR Ventures
Magnus Persson
Founding Partner at EIR Ventures
Peter Hirth
Advisor and Angel Investor at EIR Ventures
Stephan Christgau
Founding Partner at EIR Ventures